Associated Banc-Corp’s Eli Lilly & Co Position
Does Associated Banc-Corp own Eli Lilly & Co (LLY)? Yes — 59.1K shares worth $54M (+1.44% of its 13F portfolio) as of Q1 2026, up from 58.0K shares the prior filed quarter.
Position Value
$54M
Q1 2026
Shares
59.1K
% of Portfolio
+1.44%
Quarters Held
16
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 59.1K | $54M | +1.44% |
| Q4 2025 | 58.0K | $62M | +1.60% |
| Q3 2025 | 56.6K | $43M | +1.14% |
| Q2 2025 | 55.4K | $43M | +1.22% |
| Q1 2025 | 54.5K | $45M | +1.37% |
| Q4 2024 | 51.4K | $40M | +1.20% |
| Q3 2024 | 26.3K | $23M | +0.68% |
| Q2 2024 | 23.1K | $21M | +0.65% |
| Q1 2024 | 20.6K | $16M | +0.51% |
| Q4 2023 | 18.4K | $11M | +0.37% |
| Q3 2023 | 16.4K | $9M | +0.34% |
| Q2 2023 | 16.6K | $8M | +0.29% |
| Q1 2023 | 16.6K | $6M | +0.23% |
| Q4 2022 | 16.5K | $6M | +0.25% |
| Q3 2022 | 16.5K | $5M | +0.25% |
| Q2 2022 | 16.5K | $5M | +0.23% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Associated Banc-Corp’s full portfolio or all institutional holders of LLY.